Dupilumab (Atopic Dermatitis) - Forecast and Market Analysis to 2022 - a new market research report on companiesandmarkets.com
PR-Inside.com: 2014-03-19 01:07:01
Dupilumab (Atopic Dermatitis) - Forecast and Market Analysis to 2022
Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for others to follow suit.
Sanofi and Regeneron are co-developing dupilumab, a novel, fully human monoclonal antibody (mAb) directed against IL-4R a, as a potential treatment for atopic dermatitis and asthma. Atopic dermatitis is often the first manifestation of atopy (the genetic disposition to develop an allergic reaction) in many patients who later develop other atopic disorders such as allergic rhinitis, asthma, or both, in a process referred to as the atopic march or allergic march.
- Overview of Atopic Dermatitis, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on Dupilumab including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for Dupilumab for the top nine countries from 2012 to 2022.
- Sales information covered for the US, France, Germany, Italy, Spain, the UK, Japan, India and China.
Reasons to buy
- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of the competition by understanding the changing competitive landscape for Atopic Dermatitis
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of Dupilumab performance
- Obtain sales forecast for Dupilumab from 2012-2022 in top nine countries (the US, France, Germany, Italy, Spain, the UK, Japan, India and China)
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.